AI assistant
NANOSONICS LIMITED — Capital/Financing Update 2016
Apr 19, 2016
65405_rns_2016-04-19_e432892f-e974-4be1-bbc1-8cb2e9813ded.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [186 x 67] intentionally omitted <==
20 April 2016
Company Announcements Office Australian Securities Exchange
Conversion Notice in relation to Convertible Notes
Nanosonics (ASX: NAN) advises that it has received a Conversion Notice in relation to the Tranche A Convertible Note and Tranche B Convertible Note (“Convertible Notes”) issued by the Company in accordance with the Convertible Note Deed Poll dated 28 June 2012.
The current Noteholder has exercised its right under the Deed Poll to convert all of the Convertible Notes into fully paid ordinary shares in the Company.
The conversion price is $0.75 per share. The number of shares to be issued will be determined in accordance with the terms of the Deed Poll and will take into consideration the Face Value of the Convertible Notes together with any interest that has accrued and is added to the Face Value of the Convertible Notes as well as any other adjustments that may be applicable.
The timing of the issue of the shares will be determined in accordance with the timetable set out in the Deed Poll, which is expected to occur within 8 Business Days.
As set out in the Deed Poll the Convertible Notes were due to mature on 28 June 2016 unless the Noteholder elected to convert at an earlier date.
Michael Kavanagh CEO / President
For more information please contact:
Michael Kavanagh, CEO / President or McGregor Grant, CFO, on (02) 8063 1600
About Nanosonics
Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets. Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. For more information about Nanosonics please visit www.nanosonics.com.au
Nanosonics Limited ABN 11 095 076 896 14 Mars Road, Lane Cove NSW 2066 Australia Tel: +61 2 8063 1600 Fax: +61 2 8063 1600 Email: [email protected] w: www.nanosonics.com.au